Kinnate Biopharma, Inc. (KNTE)
Total Valuation
KNTE has a market cap or net worth of $555.00 million. The enterprise value is $288.96 million.
| Market Cap | 555.00M |
| Enterprise Value | 288.96M |
Important Dates
The next earnings date is Monday, August 15, 2022, before market open.
| Estimated Earnings Date | Aug 15, 2022 |
| Ex-Dividend Date | n/a |
Share Statistics
KNTE has 43.98 million shares outstanding. The number of shares has increased by 0.93% in one year.
| Shares Outstanding | 43.98M |
| Shares Change (YoY) | +0.93% |
| Shares Change (QoQ) | +0.36% |
| Owned by Insiders (%) | 0.25% |
| Owned by Institutions (%) | 94.28% |
| Float | 15.73M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 1.88 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 20.15, with a Debt / Equity ratio of 0.02.
| Current Ratio | 20.15 |
| Quick Ratio | 19.82 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -30.10%, which is considered low. The company has a ROIC of -43.40%.
| Return on Equity (ROE) | -30.10% |
| Return on Assets (ROA) | -26.30% |
| Return on Capital (ROIC) | -43.40% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.46M |
| Employee Count | 68 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -46.73% in the last 52 weeks.
| Beta (1Y) | n/a |
| 52-Week Price Change | -46.73% |
| 50-Day Moving Average | 9.40 |
| 200-Day Moving Average | 10.87 |
| Average Volume (30 Days) | 185,800 |
Short Selling Information
The latest short interest is 2.74 million, so 6.23% of the outstanding shares have been sold short.
| Short Interest | 2.74M |
| Short % of Shares Out | 6.23% |
| Short % of Float | 17.43% |
| Short Ratio (days to cover) | 14.50 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -99.69M |
| Net Income | -99.21M |
| EBITDA | -99.06M |
| EBIT | -99.21M |
| Earnings Per Share (EPS) | -$2.27 |
Balance Sheet
The company has $270.63 million in cash and $4.60 million in debt, giving a net cash position of $266.04 million or $6.05 per share.
| Cash & Cash Equivalents | 270.63M |
| Total Debt | 4.60M |
| Net Cash | 266.04M |
| Net Cash Per Share | $6.05 |
| Book Value | 295.82M |
| Book Value Per Share | 6.73 |
| Working Capital | 261.54M |
Cash Flow
In the last 12 months, operating cash flow was -$78.71 million and capital expenditures -$2.78 million, giving a free cash flow of -$81.49 million.
| Operating Cash Flow | -78.71M |
| Capital Expenditures | -2.78M |
| Free Cash Flow | -81.49M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
KNTE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -17.88% |
| FCF Yield | -14.68% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.93% |
| Shareholder Yield | -0.93% |
Analyst Forecast
The average price target for KNTE is $35.02, which is 177.50% higher than the current price. The consensus rating is "Buy".
| Price Target | $35.02 |
| Price Target Difference | 177.50% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |